Combinex Cattle 2.2Lt (New)

Target Species Non-lactating cattle. Indications for use, specifying target species For the treatment and control of parasitic bronchitis, parasitic gastro-enteritis and fascioliasis in cattle. When used at the recommended dose rate, the product is effective against mature and developing immature stages of Levamisole susceptible Haemonchus, Trichostrongylus, Cooperia, Nematodirus, Bunostromum and Oesophagostomum species in the gastro-intestinal tract, and Dictyocaulus spp in the lungs. The product is effective against developing immature and adult Ostertagia, but is not active against inhibited larvae. It is also effective against all stages of Triclabendazole susceptible Fasciola hepatica from two week old early immature to adult fluke, and so is indicated against both acute and chronic fascioliasis. Contra-indications None Special warnings for each target species Efficacy of this product against roundworms is reduced if levamisole resistant strains are present. Efficacy of this product against liver fluke is reduced if triclabendazole resistant strains are present. Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: ∙ Too frequent and repeated use of anthelmintics from the same class, over an extended period of time ∙ Underdosing which may be due to underestimation of body weight, misadministration of the product or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Resistance to levamisole has been reported in Teladorsagia species in cattle in developed countries such as New Zealand. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of the nematodes and recommendations on how to limit further selection for resistance to anthelmintics. Special precautions for use i. Special precautions for use in animals Assess bodyweight as accurately as possible before calculating the dosage. Clean drenching equipment before and after use. Shake container thoroughly before use and use undiluted product from the original container. Intensive use or misuse of anthelmintics can give rise to resistance. To reduce this risk, dosing programmes should be discussed with your Veterinary Adviser. ii. Special precautions to be taken by the person administering the product When administering, do not eat, drink or smoke. Wash splashes from eyes and skin immediately. Immediately remove any contaminated clothing. Wash hands and exposed skin before meals and after work. Levamisole can cause idiosyncratic reactions and serious blood disorders in a very small number of people. If symptoms such as dizziness, nausea, vomiting or abdominal discomfort are experienced when using the product, or sore mouth/throat or fever occurs shortly afterwards, then medical advice should be sought immediately Adverse reactions (frequency and seriousness) When the product is used at the recommended dose rate side effects are rare. At higher dosages, transient side effects due to levamisole may occur (i.e. salivation and slight muscle tremors). Use during pregnancy, lactation or lay The product can be administered safely to pregnant cattle. For dairy cattle, see section Withdrawal Period(s). Interaction with other medicaments and other forms of interaction Do not treat simultaneously with products containing organophosphorus compounds.
Vat Rate: 20%